Top News

Recipharm to Acquire Consort Medical for $649 Million

November 19, 2019

If successful, the acquisition will boost Recipharm’s global position in the contract development and manufacturing organization (CDMO) market.

Roche Acquires Promedior Molecule Portfolio For Up to $1.4 Billion

November 18, 2019

Through the agreement, Roche will gain full rights to the company’s portfolio of molecules for fibrotic diseases, most notably PRM-151, Promedior’s lead product candidate.

Pfizer Announces New Company Name for Mylan and Upjohn Combination

November 14, 2019

The new company name, Viatris, derives from Latin and represents the company’s main goals.

Amgen Enters into Collaboration with BeiGene for $2.7 Billion

November 07, 2019

The transaction is expected to be finalized in early 2020.

Roche and Dicerna Enter Collaboration Worth up to $1.67 Billion

November 01, 2019

The partnership will center on the development and commercialization of DCR-HBVS, Dicerna’s investigational therapy in Phase I clinical development, using its proprietary RNAi platform technology.

Sartorius Acquires Danaher Life Science Businesses for $750 million

October 24, 2019

The transaction is set to be completed in the first quarter of 2020.

GSK Divests Vaccines to Bavarian Nordic for up to $1.1 Billion

October 22, 2019

The transaction is anticipated to close by the end of 2019.

Sanofi Opens New Digital Manufacturing Facility in Massachusetts

October 16, 2019

The new location is one of the world’s first digital facilities to use intensified, continuous biologics production technology.

Alexion to Acquire Achillion for $930 Million

October 16, 2019

The transaction gives Alexion access to Achillion’s portfolio of oral small-molecule Factor D inhibitors to treat people with complement alternative pathway-mediated rare diseases.

UCB to Acquire Ra Pharmaceuticals for $2.1 Billion

October 11, 2019

The transaction is set to be completed at the end of the first quarter of 2020.